Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.

× No keyword cloud information.

17 in total

1. The clinical results of oral and parenteral administration of 2-(N'p-tolyl-N'-m-hydroxyphenylaminomethyl) imidazoline hydrochloride (regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects.

Authors: J H MOYER; C CAPLOVITZ
Journal: Am Heart J Date: 1953-04 Impact factor: 4.749

2. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.

Authors: E Gilmore; J Weil; C Chidsey
Journal: N Engl J Med Date: 1970-03-05 Impact factor: 91.245

3. Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment.

Authors: R Sannerstedt; J Stenberg; A Vedin; C Wilhelmsson; L Werkö
Journal: Am J Cardiol Date: 1972-05 Impact factor: 2.778

4. Alpha and beta adrenergic blockade in hypertension.

Authors: L J Beilin; B E Juel-Jensen
Journal: Lancet Date: 1972-05-06 Impact factor: 79.321

5. A random-zero sphygmomanometer.

Authors: B M Wright; C F Dore
Journal: Lancet Date: 1970-02-14 Impact factor: 79.321

6. Experience with the random-zero sphygmomanometer.

Authors: J G Evans; I A Prior
Journal: Br J Prev Soc Med Date: 1970-02

7. Phentolamine and cardiovascular performance.

Authors: L Gould; M Zahir; S Ettinger
Journal: Br Heart J Date: 1969-03

8. Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.

Authors: W Aenishänslin; J Pestalozzi-Kerpel; U C Dubach; P R Imhof; M Turri
Journal: Eur J Clin Pharmacol Date: 1972-06 Impact factor: 2.953

9. Adrenergic receptors, drugs, and the cardiovascular system. (1).

Authors: N C Moran
Journal: Mod Concepts Cardiovasc Dis Date: 1966-06

10. Treatment of hypertension with propranolol.

Authors: B N Prichard; P M Gillam
Journal: Br Med J Date: 1969-01-04

16 in total

1. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.

Authors: D A Richards; J Tuckman; B N Prichard
Journal: Br J Clin Pharmacol Date: 1976-10 Impact factor: 4.335

2. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.

Authors: G Koch
Journal: Br Heart J Date: 1979-02

Review 3. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.

Authors: W H Frishman
Journal: Cardiovasc Drugs Ther Date: 1988-09 Impact factor: 3.727

4. Circulatory and alpha-adrenoceptor blocking effects of phentolamine.

Authors: D A Richards; E P Woodings; B N Prichard
Journal: Br J Clin Pharmacol Date: 1978-06 Impact factor: 4.335

Review 5. The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors: B N Prichard
Journal: Br J Clin Pharmacol Date: 1978-05 Impact factor: 4.335

6. A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.

Authors: E van der Veur; B S ten Berge; A J Donker; J F May; F H Schuurman; H Wesseling
Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953

Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.